1. Changing kidney allocation policy in France: the value of simulation
- Author
-
Christian Jacquelinet, Audry, B., Golbreich, C., Antoine, C., Rebibou, J. M., Claquin, J., Loty, B., Direction Médicale et Scientifique, Agence de la biomédecine [Saint-Denis la Plaine], Laboratoire d'Informatique Médicale (LIM), Université de Rennes (UR), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Saas, Philippe, Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Franche-Comté (UFC), and Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])
- Subjects
Tissue and Organ Procurement ,MESH: Humans ,[SDV.IMM] Life Sciences [q-bio]/Immunology ,Health Policy ,Histocompatibility Testing ,Models, Theoretical ,MESH: Histocompatibility Testing ,MESH: Tissue and Organ Procurement ,Kidney Transplantation ,Article ,Resource Allocation ,MESH: Kidney Transplantation ,MESH: France ,Humans ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,MESH: Health Policy ,MESH: Resource Allocation ,France ,sense organs ,skin and connective tissue diseases ,MESH: Models, Theoretical - Abstract
International audience; This paper advocates the value of simulation to promote changes in kidney allocation. Due to the scarcity of organs and to the competition between transplantation centers to obtain the best organs for their patients, any change in organ allocation policy remains a sensitive issue in public health decision-making. Organ allocation is not easily available for prospective experimental study. Observational stud-ies only support limited changes. A simulation tool in this context permits the comparison of observed results against simulated ones. In our experience in France, it has shown to be a helpful tool during the allocation design phase providing objective facts for the debates and increasing the potential for change.
- Published
- 2006